A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.

@article{Staudacher2017ADL,
  title={A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.},
  author={Heidi M. Staudacher and Miranda C E Lomer and Freda M. Farquharson and Petra Louis and Francesca Fava and Elena Franciosi and Matthias Scholz and Kieran Michael Tuohy and James O. Lindsay and Peter M. Irving and Kevin Whelan},
  journal={Gastroenterology},
  year={2017},
  volume={153 4},
  pages={
          936-947
        }
}
BACKGROUND & AIMS Dietary restriction of fermentable carbohydrates (a low FODMAP diet) has been reported to reduce symptoms in some patients with irritable bowel syndrome (IBS). We performed a randomized, placebo-controlled study to determine its effects on symptoms and the fecal microbiota in patients with IBS. METHODS We performed a 2×2 factorial trial of 104 patients with IBS (18-65 years old), based on the Rome III criteria, at 2 hospitals in the United Kingdom. Patients were randomly… 

Figures and Tables from this paper

Clinical effectiveness of adding probiotics to a low FODMAP diet: Randomized double-blind placebo-controlled study

It was seen that adding probiotics to a low FODMAP diet does not make an additional contribution to symptom response and adherence to the diet, which has highly positive effects on symptoms of all subtypes of IBS.

Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome

This study suggests that patients with IBS under an LF-GFD had a significant improvement in IBS symptoms severity, with reduced FC level following normalization of their gut microbiota composition.

Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.

The IBS CC web application was shown to be practical, safe, and useful for clinical decision making in the long-term management of IBS, and the response to treatments could not be explained by the composition of the microbiota.

Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial (Preprint)

The IBS CC web application was shown to be practical, safe, and useful for clinical decision making in the long-term management of IBS and responses to either of the two treatments were not able to be predicted using patients’ microbiota.

Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis

In a network analysis, a low FODMAP diet ranked first for abdominal pain severity, abdominal bloating or distension severity and bowel habit, although for the latter it was not superior to any other intervention.

Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.

It is concluded that a 4-week diet low in FODMAPs is safe and effective for managing persistent gut symptoms in patients with quiescent IBD and significant improvements in specific symptom scores and numbers reporting adequate symptom relief are found.

Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis

Lactobacillus was the most effective component for the relief of IBS symptoms; Bifidobacterium and Bacillus were possibly effective and need further verification.

Low FODMAP diet in irritable bowel syndrome: a review of recent clinical trials and meta-analyses

Quality trials of the low FODMAP diet are emerging and have been transformational in supporting the widespread application to IBS management in some areas, whereas other areas still require considerable improvements in research evidence.
...

References

SHOWING 1-10 OF 38 REFERENCES

Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.

A diet low in FODMAPs reduces IBS symptoms as well as traditional IBS dietary advice, and combining elements from these 2 strategies might further reduce symptoms of IBS.

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.

In a controlled, cross-over study of patients with IBS, a diet low in FODMAPs effectively reduced functional gastrointestinal symptoms and high-quality evidence supports its use as a first-line therapy.

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.

A low FODMAP diet appears to be more effective than standard dietary advice for symptom control in IBS.

Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.

Both LFD and LGG are efficatious in patients with IBS and are investigated whether LFD or LGG could reduce IBS-SSS and improve QOL in IBS patients.

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial

IBS symptoms are linked to FODMAP content and associated with alterations in the metabolome, and in subsets of patients, FOD MAPs modulate histamine levels and the microbiota, both of which could alter symptoms.

Mechanisms and efficacy of dietary FODMAP restriction in IBS

An emerging body of research now demonstrates the efficacy of fermentable carbohydrate restriction in IBS; however, limitations still exist with this approach owing to a limited number of randomized trials, in part due to the fundamental difficulty of placebo control in dietary trials.

Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome

It is suggested that an LFSD may be effective in decreasing GI symptoms in children with IBS and microbial factors such as gut microbiome composition and stool metabolites while on the diet may relate to LFSD efficacy.

Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis

Probiotics are effective treatments for IBS, although which individual species and strains are the most beneficial remains unclear, and the efficacy of all three therapies in CIC is also uncertain.

Diets that differ in their FODMAP content alter the colonic luminal microenvironment

A low FODMAP diet reduces symptoms of IBS, but reduction of potential prebiotic and fermentative effects might adversely affect the colonic microenvironment, and diets differing in FodMAP content have marked effects on gut microbiota composition.

Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.

It is suggested that a diet low in FODMAPs is an efficacious treatment solution in the management of functional bowel symptoms for IBS and IBD patients.